Dendrimer Based Nanomedicine: Engineering Nanoparticle "Critical Nanoscale Design Parameters (CNDP') as an Optimization Strategy from Discovery to Clinical Translation
Speaker: Prof. Dr. Donald Tomalia, Distinguished Visiting Professor, Columbia University, NY, Affiliate Professor, Virginia Commonwealth University, Richmond, Adjunct Professor, University of Pennsylvania, Philadelphia, CEO & Founder NanoSynthons LLC National Dendrimer & Nanotechnology Center Mt. Pleasant, MI (USA)
"Guidance for Publishing, Strategies for Marketing, Translation and Development in Nanomedicine"
Chair Dr. Jan Mous, CEO, Pharmida AG, Basel (CH)
Day 1 Hall Sydney
CLINAM 2015
The European Summit for Clinical Nanomedicine and Targeted Medicine – The Translation to Knowledge Based Medicine
Eighth Conference and Exhibition,
June 29 2015
